Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review

NCT03047083 · clinicaltrials.gov ↗

COMPLETED

Status

1027

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

OTHER: Treatment patterns among AML patients
OTHER: AML-related healthcare resources

Sponsor

Astellas Pharma Global Development, Inc.